News
Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
July 7, 2010 8:33 am | by Bio-Medicine.Org | CommentsCINCINNATI , July 7 /PRNewswire-USNewswire/ -- Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according...
Genetically reprogrammed HSV given systemically shrinks distant sarcomas
July 7, 2010 7:37 am | by EurekAlert | Comments(Cincinnati Children's Hospital Medical Center) Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice -- still an elusive goal when treating humans with cancer,...
Researchers demystifying complex cellular communications hubs found in sensory neurons
July 7, 2010 7:37 am | by EurekAlert | Comments(American Society for Biochemistry and Molecular Biology) It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood -- underestimated, even.
Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany
July 7, 2010 7:37 am | by EurekAlert | Comments(European Society of Cardiology) Frontiers in Cardiovascular Biology, the first scientific meeting ever organized by the Council on Basic Cardiovascular Science of the European Society of Cardiology, is being held in Berlin this month to provide a new European platform for the...
Draper working on inner ear drug delivery device
July 7, 2010 7:37 am | by I-Micronews | CommentsDraper Laboratory from Cambridge, MA, is developing a new implantable device that can deliver drugs right to the inner ear.
Bio2 takes $1M for orthopedic materials tech
July 7, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | CommentsWoburn medical device firm Bio2 Technologies Inc. has taken in $1.1 million in equity financing. The company makes tissue engineering scaffolds, intended for orthopedic use.
Hospital study suggests that early transfusion increases acute upper GI re-bleeding risk
July 7, 2010 7:34 am | by EurekAlert | Comments(Wiley-Blackwell) Doctors have called for an urgent review of transfusion policies after a UK-wide study of 221 hospitals found that patients admitted with acute upper gastrointestinal bleeding are more than twice as likely to suffer further bleeding if they receive a red blood...
Meridian Bioscience signs deal with DiaSorin
July 7, 2010 6:45 am | by The Associated Press | CommentsMedical test kit maker Meridian Bioscience Inc. said Wednesday it signed a royalty-based development and distribution deal with DiaSorin S.p.A. Under the deal, DiaSorin will use key Meridian technology to develop several infectious disease products for use on their Liaison automated detection...
Excelimmune lands $4.5M funding
July 7, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | CommentsWoburn-based biopharmaceutical firm Excelimmune Inc. has taken in $4.5 million of a planned $8.9 million equity financing, according to a regulatory filing. The company develops therapies using human recombinant polyclonal antibodies.
Affymetrix cuts 2Q revenue guidance
July 7, 2010 5:45 am | by The Associated Press | CommentsAffymetrix Inc., which makes genetic testing technology, said Wednesday it is cutting revenue guidance for the second quarter, citing delayed equipment purchases, budget cuts, and a weaker euro.The company now expects to report revenue between $71 million and $72 million, down from prior...
Gentiva's Odyssey purchase clears waiting period
July 7, 2010 5:45 am | by The Associated Press | CommentsHome health care provider Gentiva Health Services Inc. said Wednesday a required waiting period has expired for its $912 million acquisition of hospice firm Odyssey HealthCare Inc. and it expects to complete the deal in the third quarter.Gentiva, which is based in Atlanta, said the waiting...
Zweena Selects ITelagen to Host Personal Health Records Application
July 7, 2010 5:35 am | by Bio-Medicine.Org | CommentsWEST WINDSOR, N.J. , July 7 /- ITelagen, a leading provider of electronic health record (EHR) hosting and management announced that it was selected by Zweena, LLC of West Windsor, NJ to host their Zweena Health Record, personal health record application. ITelagen, which was selected for...
Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
July 7, 2010 5:34 am | by Bio-Medicine.Org | CommentsBEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), today announced it will present at the...
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
July 7, 2010 5:34 am | by Bio-Medicine.Org | CommentsEAST NORRITON, Pa. , July 7 /- Tengion Inc. (Nasdaq: TNGN ) today announced that it has appointed Sunita B. Sheth , M.D., to the position of Chief Medical Officer, Vice President, Clinical and Regulatory Affairs. In this role, Dr. Sheth will be responsible for developing clinical...
Kindred says Medicare changes will cut revenue
July 7, 2010 4:45 am | by The Associated Press | CommentsHealth care services company Kindred Healthcare Inc. said Wednesday changes in Medicare reimbursements will likely reduce the company's Medicare revenue from Part B therapy services by about $11 million annually.The company had overall revenue of $4.27 billion in 2009, which means the expected...
